EN PT


0441/2017 - Does associativism is good for health? The rare disease’s case.
O associativismo faz bem à saúde? O caso das doenças raras.

Author:

• Rogério Lima Barbosa - Barbosa, RL - <rogerio.limab@gmail.com>
ORCID: http://orcid.org/0000-0003-1021-8794

Co-author(s):

• Sílvia Portugal - Portugal, S - <sp@fe.uc.pt>


Abstract:

Based on the question of an inspiring work – \"Is the market good for Health?\" (1), this paper makes a similar question, centered on associativism and the field of rare diseases. Startingthe research carried out in the scope of the Master\'s Degree in Sociology of the School of Economics of the University of Coimbra, this text puts into perspective the formulations created for the field of genetic conditions that, mainly, departan Eurocentric vision. The field of rare diseases is analyzed, identifying the roles, relationships and motivations of the different actors, namely, civil associations, pharmaceutical industry, academy, government, and families. The analysis highlights the preponderance of the market and the production of medicines, identifying a governance model - Utility Model of Care - in which the person who suffers and his/her family are emptied of their subjectivity and transmuted into medication and market agents.

Keywords:

rare disease, care, associativism, governance.

Content:

Access Issue in Scielo

Other languages:







How to

Cite

Barbosa, RL, Portugal, S. Does associativism is good for health? The rare disease’s case.. Cien Saude Colet [periódico na internet] (2017/Nov). [Citado em 28/09/2024]. Está disponível em: http://cienciaesaudecoletiva.com.br/en/articles/does-associativism-is-good-for-health-the-rare-diseases-case/16493?id=16493&id=16493



Execution



Sponsors